Copyright
©The Author(s) 2016.
World J Gastrointest Endosc. Jan 25, 2016; 8(2): 40-55
Published online Jan 25, 2016. doi: 10.4253/wjge.v8.i2.40
Published online Jan 25, 2016. doi: 10.4253/wjge.v8.i2.40
Lesions for which endoscopic en bloc resection is required |
(1) Lesions for which en bloc resection with snare EMR is difficult to apply |
LST-NG, particularly LST-NG pseudo-depressed type |
Lesions showing a Vi-type pit pattern |
Carcinoma with shallow T1 submucosal invasion |
Large depressed-type tumors |
Large protruded-type lesions suspected to be carcinoma. Including LST- G, nodular mixed type |
(2) Mucosal tumors with submucosal fibrosis as a result of a previous biopsy or prolapse caused by intestinal peristalsis |
(3) Sporadic localized tumors in conditions of chronic inflammation such as ulcerative colitis |
(4) Local residual or recurrent early carcinomas after endoscopic resection |
Ref. | Patients, n(% rectal) | Study design | Enrollmentperiod | Size(mm) | Time(min) | En bloc(%) | R0(%) | Perforationrate(%) | Delayedbleeding(%) | Hospitalstay(d) | Follow-up |
Fujishiro et al[63], 2006 | 35 (100) | Prospective | Feb 2001 Feb 2005 | 32.8 | NS | 88.6 | 62.9 | 5.7 | 28.6 | - | Missing rate: n = 0; 0% Mean: 36 mo (12-60) Recurrence rate at 2 mo: 2.8% 31/32 (96.8%) recurrence-free at 3 yr |
Tamegai et al[64], 2007 | 71 (23.9) | NS | Jan 2003 Dec 2005 | 32.7 | 61.1 | 98.6 | 95.6 | NS | 1.4 | - | Missing rate: n = 7; 9.86% Mean: 12.2 mo (range 3-34) Recurrences: 0% |
Hurlstone et al[70], 2007 | 42 (33.3) | Prospective | Mar 2004 Aug 2006 | 31 | 48 | 78.6 | 73.8 | 2.4 | 2.4 | 22 | Missing rate: n = 6; 14.3% Median: 6 mo (range: 3-18) Recurrences 4/36 (11%) Curative resections at 6 mo: 34/42 (81%) |
Fujishiro et al[112], 2007 | 200 (26) | NS | Jul 2000 Mar 2006 | 29.9 | - | 91.5 | 70.5 | 6 | 0.5 | - | Median: 18 mo (range 12-60) Recurrences: 1.8% |
Saito et al[65], 2007 | 200 (30.5) | NS | Oct 2003 Jul 2006 | 35 | 90 | 84 | 70 | 5 | 2 | 5 | Median: 7 mo Missing rate: 10% Recurrences: 0.5% |
Tanaka et al[68], 2007 | 70 (48.6) | NS | < Dec 2005 | 28 | 70.5 | 80 | - | 10 | 1.4 | - | In curative resections, 0% recurrence rate Other information not provided |
Zhou et al[113], 2009 | 74 (56.7) | NS | Jul 2006 Dec 2007 | 32.6 | 110 | 93.2 | 89.2 | 8.1 | 1.4 | - | Missing rate: n = 0; 0% Median: 14.3 mo (range 3-22) Recurrences: 0% |
Isomoto et al[114], 2009 | 292 (26.7) | NS | May 2001 Dec 2008 | 26.8 | - | 90.1 | 79.8 | 7.9 | 0.7 | - | Missing rate: 24.6% Median: 33 mo in R0 36 mo in non-R0 resections R0: 0% recurrences 1 recurrence in non-R0 resections |
Saito et al[115], 2009 | 405 (27.4) | NS | NS | 40 | 90 | 86.9 | - | 3.5 | 1 | - | Mean ± SD: 20 ± 13 mo 2% recurrences |
Iizuka et al[62], 2009 | 44 (59) | Retrospective | Jan 2000 Dec 2004 | 39 | 110 | 61 | 58 | 8 | - | - | - |
Niimi et al[60], 2010 | 310 (26.1) | Retrospective Monocentric | Jul 2000 Dec 2008 | 28.9 | - | 90.3 | 74.5 | 4.8 | 1.3 | - | Median: 38.7 mo (12.8-104.2) 2% recurrences 3-yr overall/disease-specific survivals: 97.1%/100% 5-yr overall/disease-specific survivals: 95.3%/100% 8 died of other coexisting diseases 0 died of CRC |
Yoshida et al[116], 2010 | 250 (31.6) | NS | Apr 2005 Mar 2010 | 29.6 | 106 | 86.8 | 81.2 | 6 | 2.4 | - | - |
Saito et al[81], 2010 | 145 (50.3) | Retrospective | Jan 2003 Dec 2006 | 37 | 108 | 84 | - | 6.2 | 1.4 | - | Median: 20 mo 2.1% recurrences |
Hotta et al[38], 2010 | 120 (27.5) | NS | Jun 2003 Sep 2008 | > 30 | 141 | 93.3 | 85 | 7.5 | - | - | - |
Saito et al[12], 2010 | 1111 (30.3) | Multicentric Prospective | Jun 1998 Feb 2008 | 35 | 116 | 88 | 89 | 5.3 | 1.5 | - | - |
Toyonaga et al[117], 2010 | 268 (25.7) | Retrospective | May 2002 May 2007 | 40.3 | 64.5 | 99.2 | 98.1 | 2.2 | 0.37 | - | Median: 32.2 mo (6.5-85.2) Follow-up: 227 out of the 241 curative resections (94.2%) Missing rate: 5.8% Recurrences: 0% |
Matsumoto et al[118], 2010 | 203 (NS) | NS | Nov 2002 Jun 2009 | 33 | - | 85.7 | - | 6.9 | - | - | - |
Uraoka et al[119], 2011 | 202 (32.7) | NS | Apr 2006 Mar 2010 | 40 | - | 91.6 | 87.1 | 2.4 | 0.5 | - | Median: 11.4 mo Missing rate: 14% 0% disease specific mortality 1.5% overall mortality |
Shono et al[61], 2011 | 137 (26.2) | NS | Apr 2007 Oct 2010 | 29.2 | 79.2 | 89.1 | 85.4 | 3.6 | 3.6 | - | 0% recurrences No other information provided |
Kim et al[120], 2011 | 108 (44) | Retrospective | Mar 2007 Feb 2009 | 27.6 | 61.9 | - | 78.7 | 20.4 | - | - | - |
Lee et al[84], 2012 | 314 (19.1) | Retrospective | Jan 2004 Nov 2009 | 28.9 | 54.7 | 92.7 | 87.6 | 8 | 0.64 | 3.6 | - |
Lee et al[121], 2012 | 499 (18.1) | Retrospective | Oct 2006 Nov 2010 | 28.9 | 61.3 | 95 | - | 7.4 | - | 3.6 | - |
Hisabe et al[122], 2012 | 200 (30) | NS | Jun 2003 Jun 2011 | 32.7 | 108.9 | 86 | - | 7 | 1 | - | - |
Saito et al[123], 2012 | 1321 (25.6) | Multicentric | - | 34.2 | 90 | 95.4 | 87.2 | 2.9 | 2.5 | - | - |
Okamoto et al[71], 2013 | 30 (50) | NS | Dec 2010 Aug 2012 | 36 | 61 | - | 100 | 0 | 0 | - | - |
Lee et al[72], 2013 | 874 (20.7) | Retrospective | > Oct 2006 | 26.5 | 53.8 | 97.1 | 90.5 | 6.1 | 0.5 | 3.5 | - |
Nakajima et al[80], 2013 | 816 (36.3) | Prospective Multicentric | Oct 2007 Dec 2010 | 39.4 | 96 | 94.5 | 90.6 | 2 | 2.2 | - | - |
Nawata et al[124], 2014 | 150 (20.6) | Retrospective 2 groups: A < 50 mm/B ≥ 50 mm | Apr 2010 Jul 2013 | 26/59 | 38/86 | 98.7 | 97.3 | 0 | 0 | - | - |
Sakamoto et al[66], 2014 | 164 (38) | Retrospective | Apr 2005 Mar 2012 | 30 | 95 | 95 | 92 | 4 | 3 | - | - |
Saito et al[109], 2014 | 900 (NS) | NS | NS | 40 | 100 | 91 | 87 | 2.7 | 1.7 | - | - |
Lee et al[125], 2015 | 173 (24.3) | Retrospective | Jan 2010 Dec 2013 | 25.95 | - | 88.4 | 81.5 | 11 | 3.4 | - | - |
Rahmi et al[67], 2015 | 28 (25) | Retrospective 100% recurrences | Dec 2008 Jul 2013 | 17.5 | 63 | 96.4 | 92.9 | 3.5 | 0 | 7 | Median: 22 mo Missing rate: 35.7% Recurrences: 0% |
Ref. | Patients, n (% rectal) | Study design | Enrollment period | Size (mm) | Time (min) | En bloc (%) | R0 (%) | Perforation rate (%) | Delayed bleeding (%) | Hospital stay (d) | Follow-up |
Farhat et al[16], 2011 | 85 (84.7) | Prospective | Jan 2008 Aug 2010 | - | - | 67 | 62.3 | - | - | - | - |
Probst et al[14], 2012 | 76 (86.6) | NS | Oct 2004 Sep 2011 | 45.8 | 176 | 81.6 | 69.7 | 6.6 | 10.5 | - | Median: 23.6 mo (2-83) Included in follow-up: n = 65 9.2% residual neoplasms (5 piecemeal and 1 en bloc R1 lateral) |
Repici et al[20], 2013 | 40 (100) | Prospective | Apr 2010 Jan 2011 | 46.8 | 86.1 | 90 | 80 | 5 | 2.5 | - | Recurrences: 2.5% |
Thorlacius et al[126], 2013 | 29 (59) | NS | Jan 2012 Mar 2013 | 28 | 142 | 72 | 69 | 6.9 | 0 | - | Recurrences: 0% at 3-6 mo Missing rate: 82.7% |
Spychalski et al[127], 2015 | 70 (56) | NS | Jun 2013 Jun 2014 | 30 | 110 | 66 | - | 8 | 6 | - | Missing rate: 14.6% Recurrences: 4.9% Follow-up < 12 mo |
Rahmi et al[128], 2014 | 45 (100) | NS | Feb 2010 Jun 2012 | 35 | 110 | 64 | 53 | 18 | 13 | 3.4 | For curative resections at 12 mo: 88% |
Bialek et al[129], 2014 | 37 (67.6) | Prospective | 2007 2013 | 37 | 70 | 86.5 | 81.1 | 0 | 5.7 | - | At 1-yr follow-up: 1.7% recurrences |
- Citation: Marín-Gabriel JC, Fernández-Esparrach G, Díaz-Tasende J, Herreros de Tejada A. Colorectal endoscopic submucosal dissection from a Western perspective: Today’s promises and future challenges. World J Gastrointest Endosc 2016; 8(2): 40-55
- URL: https://www.wjgnet.com/1948-5190/full/v8/i2/40.htm
- DOI: https://dx.doi.org/10.4253/wjge.v8.i2.40